GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 74 filers reported holding GOSSAMER BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $270,816 | -81.5% | 124,800 | +2.0% | 0.00% | -100.0% |
| Q3 2022 | $1,465,000 | +61.9% | 122,300 | +13.1% | 0.00% | 0.0% |
| Q2 2022 | $905,000 | -11.3% | 108,100 | -8.0% | 0.00% | 0.0% |
| Q1 2022 | $1,020,000 | -17.1% | 117,500 | +8.0% | 0.00% | 0.0% |
| Q4 2021 | $1,231,000 | -10.0% | 108,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,368,000 | +54.9% | 108,800 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $883,000 | -14.3% | 108,800 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $1,030,000 | -4.4% | 111,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,077,000 | -27.5% | 111,400 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $1,485,000 | -3.1% | 119,700 | +1.5% | 0.00% | 0.0% |
| Q2 2020 | $1,533,000 | +298.2% | 117,900 | +211.1% | 0.00% | – |
| Q1 2020 | $385,000 | -35.0% | 37,900 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $592,000 | -4.2% | 37,900 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $618,000 | -24.3% | 36,800 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $816,000 | – | 36,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |